ロード中...

Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects

This open‐label, single‐sequence study in healthy subjects investigated the effects of steady‐state carbamazepine on the pharmacokinetic (PK) profile of a single 2‐mg dose of fingolimod. In period 1, a single oral dose of fingolimod 2 mg (day 1) was followed by PK and safety assessments up to 36 day...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacol Drug Dev
主要な著者: David, Olivier J., Behrje, Rhett, Pal, Parasar, Hara, Hisanori, Lates, Christian D., Schmouder, Robert
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099239/
https://ncbi.nlm.nih.gov/pubmed/29694732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.459
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!